Zoetis (ZTS) Research & Development (2012 - 2026)
Zoetis (ZTS) posted quarterly Research & Development of $180.0 million for Q1 2026, up 11.11% year-over-year from $162.0 million in Q1 2025, and down 9.55% quarter-over-quarter from $199.0 million in Q4 2025.
Zoetis (ZTS) Research & Development (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Research & Development for 13 consecutive years, with $180.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 11.11% year-over-year to $180.0 million; the TTM figure through Mar 2026 stood at $721.0 million (up 5.1% YoY), while the FY2025 annual figure was $698.0 million, up 1.75% from the prior year.
- Research & Development slipped to $180.0 million in Q1 2026 per ZTS's latest filing, from $199.0 million in the prior quarter.
- Across five years, Research & Development topped out at $199.0 million in Q4 2025 and bottomed at $122.0 million in Q1 2022.
- Historically, Research & Development has averaged $160.1 million across 5 years, with a median of $162.0 million in 2024.
- Annual changes were most pronounced in 2023 — Research & Development advanced 17.57% — and 2025, when it changed 0.0%.
- Zoetis' Research & Development stood at $148.0 million in 2022, then increased by 17.57% to $174.0 million in 2023, then advanced by 6.9% to $186.0 million in 2024, then gained by 6.99% to $199.0 million in 2025, then retreated by 9.55% to $180.0 million in 2026.
- Business Quant data shows ZTS's Research & Development at $180.0 million in Q1 2026, $199.0 million in Q4 2025, and $170.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.71 Bn | 42.75 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.62 Bn | 29.94 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 12.10 Bn | 11.57 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.25 Bn | 7.60 Bn | 397.90 Mn | 154.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 173.00 Mn |
| Mar 31, 2026 | 180.00 Mn |
| Dec 31, 2025 | 199.00 Mn |
| Sep 30, 2025 | 170.00 Mn |
| Jun 30, 2025 | 172.00 Mn |
| Mar 31, 2025 | 162.00 Mn |
| Dec 31, 2024 | 186.00 Mn |
| Sep 30, 2024 | 167.00 Mn |
| Jun 30, 2024 | 171.00 Mn |
| Mar 31, 2024 | 162.00 Mn |
| Dec 31, 2023 | 174.00 Mn |
| Sep 30, 2023 | 152.00 Mn |
| Jun 30, 2023 | 146.00 Mn |
| Mar 31, 2023 | 142.00 Mn |
| Dec 31, 2022 | 148.00 Mn |
| Sep 30, 2022 | 134.00 Mn |
| Jun 30, 2022 | 135.00 Mn |
| Mar 31, 2022 | 122.00 Mn |
| Dec 31, 2021 | 138.00 Mn |
| Sep 30, 2021 | 132.00 Mn |